The Latest Breaking News from Hologic

FDA Says Breast Biopsy Needle Shortage Could Last into 2027 as Radiologists Triage Who Gets Scheduled First

FDA says a stereotactic breast biopsy needle shortage may last through March 2027. What patients facing a biopsy delay should know.

Medical Daily · Aug 3

Blackstone, TPG seek over $4 billion for Hologic's surgical unit

The ⁠two firms are working with advisers on ​a sale of the division, which makes surgical equipment used ​by gynecologists, FT reported.

The Economic Times · Jul 9

Don’t keep calm and carry on: British women are among the angriest in Europe, survey reveals

Long delays and dismissive attitudes within UK healthcare systems are impacting older British women especially, leaving them angrier and sadder than the rest of Europe.

Euronews · Jun 5

Is Hologic Stock Outperforming the Nasdaq?

While Hologic has underperformed the Nasdaq over the past year, it has notably outperformed in recent months, but analysts still remain cautious about the stock’s prospects.

Barchart · Dec 12, 2025

Deal Dispatch: From Four Roses Bourbon To Quantum Stakes, Here Are This Week's Sector Shake Ups

See Also: Moody’s To Benefit From MA Activity, Analysts Say

Benzinga · Oct 24, 2025

Hologic Agrees To $18.3 Billion Buyout By Blackstone And TPG

Hologic, Inc. (NASDAQ:HOLX) shares are trading higher after the company agreed to be acquired by funds managed by Blackstone Inc. (NYSE:BX) and TPG Inc. (NASDAQ:TPG) for an enterprise value of about $18.3 billion.

Benzinga · Oct 21, 2025

What to Expect From Hologic’s Next Quarterly Earnings Report

Hologic is set to release its fourth-quarter earnings next month, and analysts are forecasting a solid high-single-digit increase in profits.

Barchart · Oct 16, 2025

Is Hologic Stock Underperforming the S&P 500?

Hologic has underperformed the broader S&P 500 index over the past year. However, Wall Street analysts remain moderately optimistic about its prospects.

Barchart · Sep 22, 2025

What Are Wall Street Analysts' Target Price for Hologic Stock?

Although Hologic has underperformed the broader market over the past year, it has observed significant gains in recent months, and analysts are turning more optimistic on the stock’s prospects.

Barchart · Aug 14, 2025

How Is Hologic’s Stock Performance Compared to Other Health Care Equipment Stocks?

Hologic has outpaced its healthcare equipment peers over the past year, with analysts maintaining a moderately bullish outlook on the stock’s future performance.

Barchart · Jun 20, 2025